Nitric oxide release follows endothelial nanomechanics and not vice versa.
In the vascular endothelium, mechanical cell stiffness (К) and nitric oxide (NO) release are tightly coupled. "Soft" cells release more NO compared to "stiff" cells. Currently, however, it is not known whether NO itself is the primary factor that softens the cells or whether NO release is the result of cell softening. To address this question, a hybrid fluorescence/atomic force microscope was used in order to measure changes in К and NO release simultaneously in living vascular endothelial cells. Aldosterone was applied to soften the cells transiently and to trigger NO release. NO synthesis was then either blocked or stimulated and, simultaneously, К was measured. Cell indentation experiments were performed to evaluate К, while NO release was measured either by an intracellular NO-dependent fluorescence indicator (DAF-FM/DA) or by NO-selective electrodes located close to the cell surface. After the application of aldosterone, К decreases, within 10 min, to 80.5 ± 1.7% of control (100%). DAF-FM fluorescence intensity increases simultaneously to 132.9 ± 2.2%, which indicates a significant increase in the activity of endothelial NO synthase (eNOS). Inhibition of eNOS (by N (ω)-nitro-L: -arginine methyl ester) blocks the NO release, but does not affect the aldosterone-induced changes in К. Application of an eNOS-independent NO donor (NONOate/AM) raises intracellular NO concentration, but, again, does not affect К. Data analysis indicates that a decrease of К by about 10% is sufficient to induce a significant increase of eNOS activity. In conclusion, these nanomechanic properties of endothelial cells in vascular endothelium determine NO release, and not vice versa.
Fels
Johannes
J
Institute of Physiology II, University of Muenster, Robert-Koch-Str. 27b, 48149, Muenster, Germany. felsj@uni-muenster.de
Callies
Chiara
C
Kusche-Vihrog
Kristina
K
Oberleithner
Hans
H
D000450:Aldosterone / Q000494:pharmacology; D000818:Animals; D001696:Biomechanical Phenomena; D002417:Cattle; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D018625:Microscopy, Atomic Force / Q000379:methods; D008856:Microscopy, Fluorescence / Q000379:methods; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D036103:Nanotechnology; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D014655:Vascular Resistance / Q000187:drug effects / Q000502:physiology
D009569:Nitric Oxide; D000450:Aldosterone; D052250:Nitric Oxide Synthase Type III; D019331:NG-Nitroarginine Methyl Ester
Physiol Rev. 2009 Apr;89(2):481-534
19342613
J Cell Physiol. 1983 Mar;114(3):328-38
6833405
Hypertens Res. 2008 Sep;31(9):1811-20
18971560
Biochim Biophys Acta. 2010 Dec;1802(12):1193-202
20302930
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2829-34
19202069
Nanotechnology. 2009 Apr 29;20(17):175104
19420584
Br J Pharmacol. 2001 Apr;132(8):1876-82
11309260
Hypertension. 2003 Aug;42(2):156-60
12860833
Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L41-50
16113046
Physiol Rev. 1998 Jan;78(1):247-306
9457175
Mol Cell Endocrinol. 2004 Mar 31;217(1-2):75-9
15134804
Circ Res. 2003 Dec 12;93(12):1258-66
14615288
Exp Cell Res. 1999 Oct 10;252(1):63-74
10502400
Pflugers Arch. 2008 Apr;456(1):13-27
18213477
J Biomed Mater Res A. 2007 Jun 1;81(3):728-35
17212346
Pflugers Arch. 2001 Aug;442(5):675-87
11512023
Am J Physiol. 1997 Apr;272(4 Pt 1):E616-20
9142882
Acta Physiol Scand. 2003 Sep;179(1):85-91
12940942
Am J Physiol Renal Physiol. 2001 Jul;281(1):F189-94
11399660
J Membr Biol. 2003 Dec 1;196(3):163-72
14724742
Nature. 2007 May 31;447(7144):592-5
17538621
Eur J Vasc Endovasc Surg. 1995 Jan;9(1):86-92
7664019
Am J Physiol Cell Physiol. 2003 Jun;284(6):C1542-9
12734108
Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:15-8
15962093
J Membr Biol. 1993 Jan;131(1):55-66
8433352
Angew Chem Int Ed Engl. 1999 Nov 2;38(21):3209-3212
10556905
J Biomech. 2001 Dec;34(12):1545-53
11716856
Am J Physiol. 1997 Jul;273(1 Pt 2):H347-55
9249510
Am J Physiol. 1994 Mar;266(3 Pt 1):C628-36
8166225
Trends Biotechnol. 1999 Apr;17(4):143-50
10203772
Cardiovasc Res. 1998 Jun;38(3):655-67
9747433
Hypertension. 2006 Apr;47(4):650-5
16520409
Br J Pharmacol. 1988 Jan;93(1):229-39
2894877
Circulation. 2003 Nov 11;108(19):2400-6
14557368
Kidney Int. 2010 Mar;77(6):490-4
20054292
Am J Physiol Regul Integr Comp Physiol. 2003 Jan;284(1):R1-12
12482742
J Neurochem. 2001 Mar;76(5):1404-10
11238725
Am J Physiol. 1986 Jun;250(6 Pt 2):H1145-9
3487253
Cardiovasc Res. 2009 Jul 1;83(1):97-105
19351743
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16281-6
17911245
Physiol Rev. 2001 Oct;81(4):1415-59
11581493
Anal Biochem. 2000 Dec 15;287(2):203-9
11112265
Pflugers Arch. 2007 May;454(2):187-93
17285301
Nat Nanotechnol. 2009 Jun;4(6):389-93
19498402
Pflugers Arch. 2008 Nov;457(2):551-9
18481081
Cell Motil Cytoskeleton. 2005 Oct;62(2):124-32
16145686
J Cardiovasc Pharmacol. 2009 Dec;54(6):535-42
19770672